Pfizer to inject $130m in two manufacturing plants in Ireland
Out of the total investment, the company plans to pump an amount of $100m in its biologics operation in Grange Castle, west Dublin, Ireland and $30m in Ringaskiddy,
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.